Dabrafenib
Back to search| Scientific Name: | Dabrafenib |
| Brand Name: | Tafinlar |
| Company Owner: | Not Available |
| Mechanism Of Action | Dabrafenib is a competitive and selective BRAF inhibitor by binding to its ATP pocket. |
| Description of the Drug: | Dabrafenib is a kinase inhibitor used to treat patients with specific types of melanoma, non-small cell lung cancer, and thyroid cancer. |
| Protein Data Bank: |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB08912
